Proposition of zinc supplementation during levodopa-carbidopa intestinal gel treatment.

Hirofumi MatsuyamaKeita MatsuuraHidehiro IshikawaYoshinori HirataNatsuko KatoAtsushi NiwaYugo NaritaHidekazu Tomimoto

Published in: Brain and behavior (2018)

Levodopa-carbidopa intestinal gel infusion might have caused a zinc deficiency through levodopa zinc chelation. Zinc deficiency with LCIG infusion has not yet been reported, though preventing zinc deficiency may be an important factor in future LCIG treatment strategies.

Keyphrases

oxide nanoparticles
parkinson disease
low dose
replacement therapy
hyaluronic acid